COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Jul 2021
Historique:
received: 28 05 2021
revised: 07 07 2021
accepted: 10 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 31 7 2021
Statut: epublish

Résumé

Children with the new coronavirus disease 2019 (COVID-19) have milder symptoms and a better prognosis than adult patients. Several investigations assessed type I, II, and III interferon (IFN) signatures in SARS-CoV-2 infected adults, however no data are available for pediatric patients. TRIM28 and SETDB1 regulate the transcription of multiple genes involved in the immune response as well as of human endogenous retroviruses (HERVs). Exogenous viral infections can trigger the activation of HERVs, which in turn can induce inflammatory and immune reactions. Despite the potential cross-talks between SARS-CoV-2 infection and TRIM28, SETDB1, and HERVs, information on their expressions in COVID-19 patients is lacking. We assessed, through a PCR real time Taqman amplification assay, the transcription levels of six IFN-I stimulated genes, IFN-II and three of its sensitive genes, three IFN-lIIs, as well as of TRIM28, SETDB1, pol genes of HERV-H, -K, and -W families, and of env genes of Syncytin (SYN)1, SYN2, and multiple sclerosis-associated retrovirus (MRSV) in peripheral blood from COVID-19 children and in control uninfected subjects. Higher expression levels of IFN-I and IFN-II inducible genes were observed in 36 COVID-19 children with mild or moderate disease as compared to uninfected controls, whereas their concentrations decreased in 17 children with severe disease and in 11 with multisystem inflammatory syndrome (MIS-C). Similar findings were found for the expression of TRIM-28, SETDB1, and every HERV gene. Positive correlations emerged between the transcriptional levels of type I and II IFNs, TRIM28, SETDB1, and HERVs in COVID-19 patients. IFN-III expressions were comparable in each group of subjects. This preserved induction of IFN-λs could contribute to the better control of the infection in children as compared to adults, in whom IFN-III deficiency has been reported. The upregulation of IFN-I, IFN-II, TRIM28, SETDB1, and HERVs in children with mild symptoms, their declines in severe cases or with MIS-C, and the positive correlations of their transcription in SARS-CoV-2-infected children suggest that they may play important roles in conditioning the evolution of the infection.

Identifiants

pubmed: 34299101
pii: ijms22147481
doi: 10.3390/ijms22147481
pmc: PMC8303145
pii:
doi:

Substances chimiques

Interferon Type I 0
Interferon-gamma 82115-62-6
Interferons 9008-11-1
Histone-Lysine N-Methyltransferase EC 2.1.1.43
SETDB1 protein, human EC 2.1.1.43
TRIM28 protein, human EC 2.3.2.27
Tripartite Motif-Containing Protein 28 EC 2.3.2.27
Interferon Lambda 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Immunol Rev. 2016 Jan;269(1):85-99
pubmed: 26683147
J Allergy Clin Immunol. 2021 Jan;147(1):107-111
pubmed: 32920092
Front Cell Infect Microbiol. 2021 Feb 25;11:609160
pubmed: 33732659
JCI Insight. 2021 Jan 11;6(1):
pubmed: 33232303
Int J Mol Sci. 2020 Jun 01;21(11):
pubmed: 32492928
Vaccines (Basel). 2017 Aug 22;5(3):
pubmed: 28829373
Nat Commun. 2018 Apr 12;9(1):1424
pubmed: 29651155
Bioessays. 2012 Sep;34(9):734-8
pubmed: 22736292
PLoS One. 2012;7(9):e44991
pubmed: 23028727
J Clin Invest. 2017 Aug 1;127(8):2930-2940
pubmed: 28650338
Nat Med. 2018 Aug;24(8):1143-1150
pubmed: 30038220
Genes Dev. 1996 Aug 15;10(16):2067-78
pubmed: 8769649
J Virol. 2015 Mar;89(5):2628-42
pubmed: 25520509
J Biol Chem. 2017 May 5;292(18):7285-7294
pubmed: 28289098
Nat Immunol. 2019 Mar;20(3):326-336
pubmed: 30778252
Nat Med. 2009 Jun;15(6):696-700
pubmed: 19483695
Immunology. 2012 Jun;136(2):184-91
pubmed: 22348442
Autoimmun Rev. 2020 Aug;19(8):102597
pubmed: 32535093
J Neuroimmunol. 2016 Feb 15;291:29-38
pubmed: 26857492
J Immunol. 2006 Jun 15;176(12):7636-44
pubmed: 16751411
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
EBioMedicine. 2021 Apr;66:103341
pubmed: 33867312
Virus Res. 2021 Apr 2;295:198283
pubmed: 33418027
Genes Dev. 2002 Apr 15;16(8):919-32
pubmed: 11959841
Sci Rep. 2021 Mar 11;11(1):5760
pubmed: 33707568
Virol Sin. 2021 Dec;36(6):1315-1326
pubmed: 34009516
Nat Rev Microbiol. 2019 Jun;17(6):355-370
pubmed: 30962577
Nat Commun. 2020 Jul 6;11(1):3434
pubmed: 32632085
J Immunol. 2021 Apr 1;206(7):1528-1539
pubmed: 33619215
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Biol Reprod. 2020 Feb 12;102(1):185-198
pubmed: 31318021
Eur J Immunol. 2020 May;50(5):685-694
pubmed: 32012247
J Mol Cell Biol. 2018 Jun 1;10(3):258-266
pubmed: 29272473
Circulation. 2020 Sep 22;142(12):1190-1204
pubmed: 32755395
J Allergy Clin Immunol. 2021 Feb;147(2):510-519.e5
pubmed: 33068560
J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2
pubmed: 32360285
Nature. 1993 Apr 22;362(6422):758-61
pubmed: 8469287
PLoS One. 2015 Apr 01;10(4):e0118629
pubmed: 25831059
Front Med. 2021 Apr;15(2):252-263
pubmed: 33511555
Nature. 2021 Jun;594(7862):259-264
pubmed: 33887749
Curr Opin Immunol. 2019 Feb;56:67-75
pubmed: 30399529
Minerva Med. 2020 Jun;111(3):245-253
pubmed: 31755671
Cytokine Growth Factor Rev. 2020 Jun;53:66-70
pubmed: 32418715
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
J Virol. 2020 Sep 15;94(19):
pubmed: 32699094
Science. 2016 Mar 4;351(6277):1083-7
pubmed: 26941318
Biochem Biophys Res Commun. 2008 May 30;370(2):366-70
pubmed: 18381204
Pathogens. 2017 Feb 15;6(1):
pubmed: 28212305
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7583-8
pubmed: 9207135
J Virol Methods. 2009 Oct;161(1):98-106
pubmed: 19505508
Front Immunol. 2016 Dec 19;7:609
pubmed: 28066419
Immunity. 2017 May 16;46(5):875-890.e6
pubmed: 28514692
Nat Immunol. 2021 Jan;22(1):32-40
pubmed: 33277638
Front Immunol. 2018 Sep 28;9:2229
pubmed: 30323812
J Proteome Res. 2021 May 7;20(5):2224-2239
pubmed: 33666082
Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):E9162-E9171
pubmed: 30201712
J Cell Biol. 2015 May 25;209(4):579-93
pubmed: 26008745
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Front Pediatr. 2020 May 14;8:244
pubmed: 32478020
Retrovirology. 2012 Jan 16;9:6
pubmed: 22248111
EMBO Mol Med. 2011 Jun;3(6):348-61
pubmed: 21538995
J Virol. 2016 Apr 14;90(9):4369-4382
pubmed: 26889027
J Virol. 2007 Jan;81(2):548-57
pubmed: 17108024
J Neurovirol. 2006 Feb;12(1):65-71
pubmed: 16595376
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20083-8
pubmed: 23169648
Cell Host Microbe. 2020 Jun 10;27(6):870-878
pubmed: 32464097
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13013-8
pubmed: 14557543
J Immunol. 2011 Nov 1;187(9):4754-63
pubmed: 21940674
Cell Rep. 2020 Sep 22;32(12):108185
pubmed: 32941788
Nat Med. 2020 Oct;26(10):1623-1635
pubmed: 32807934
Cell Host Microbe. 2020 Sep 9;28(3):455-464.e2
pubmed: 32707096
mBio. 2020 Sep 10;11(5):
pubmed: 32913009
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25839-25849
pubmed: 31776254
Front Immunol. 2021 Mar 29;12:621333
pubmed: 33854500
Viruses. 2014 Nov 24;6(11):4609-27
pubmed: 25421890
Int J Mol Sci. 2021 Feb 23;22(4):
pubmed: 33672287
Pigment Cell Melanoma Res. 2011 Aug;24(4):656-65
pubmed: 21501418
Adv Immunol. 2016;132:47-69
pubmed: 27769507
Clin Exp Immunol. 1995 Aug;101(2):259-64
pubmed: 7648710
Mol Cell. 2007 Dec 14;28(5):823-37
pubmed: 18082607
Stem Cell Rev Rep. 2021 Feb;17(1):4-8
pubmed: 32399806
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
PLoS One. 2009;4(3):e4894
pubmed: 19290053
Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt B):2594-2600
pubmed: 27816520
Retrovirology. 2013 Nov 12;10:132
pubmed: 24219971
Semin Immunopathol. 2020 Dec;42(6):669-680
pubmed: 33219395
Front Immunol. 2018 Sep 10;9:2039
pubmed: 30250470
Front Immunol. 2020 Sep 29;11:585647
pubmed: 33133104
Nat Rev Microbiol. 2005 Oct;3(10):799-808
pubmed: 16175175
Nature. 2020 Aug;584(7821):463-469
pubmed: 32717743
Clin Infect Dis. 2021 Nov 16;73(10):1882-1886
pubmed: 33718968
Immunity. 2019 Mar 19;50(3):629-644.e8
pubmed: 30737147
Brain Behav Immun. 2018 Jan;67:324-334
pubmed: 28928004
Eur J Immunol. 2015 Jun;45(6):1748-59
pubmed: 25752285
Nature. 2020 Apr;580(7803):386-390
pubmed: 32296174
Gut. 2021 Mar;70(3):485-498
pubmed: 32503845
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Viruses. 2020 Dec 13;12(12):
pubmed: 33322160
J Med Virol. 2021 Apr;93(4):1983-1998
pubmed: 33300152
Pediatr Clin North Am. 2021 Feb;68(1):321-338
pubmed: 33228941
Science. 2016 Dec 2;354(6316):1165-1169
pubmed: 27789799
Autoimmunity. 2020 Aug;53(5):283-288
pubmed: 32586158
Cancers (Basel). 2020 Oct 15;12(10):
pubmed: 33076560
Nat Immunol. 2019 May;20(5):593-601
pubmed: 30886417
Science. 2020 Sep 4;369(6508):1210-1220
pubmed: 32788292
J Virol. 2013 Apr;87(8):4523-33
pubmed: 23408607
J Cell Biol. 2017 Nov 6;216(11):3535-3549
pubmed: 28887438
Trends Biochem Sci. 2007 Jun;32(6):286-95
pubmed: 17499995
EMBO Mol Med. 2020 Jun 8;12(6):e12465
pubmed: 32333818
J Virol. 2016 Sep 29;90(20):9338-49
pubmed: 27512062
Cell. 2021 Jan 7;184(1):149-168.e17
pubmed: 33278357
Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):E3798-E3807
pubmed: 29610295
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32518072
Stem Cell Res. 2017 Aug;23:163-172
pubmed: 28759843
Semin Immunol. 2019 Jun;43:101303
pubmed: 31771761
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
J Virol. 2000 Apr;74(7):3321-9
pubmed: 10708449
Viral Immunol. 2004;17(4):498-515
pubmed: 15671747
Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17399-17408
pubmed: 31391303

Auteurs

Pier-Angelo Tovo (PA)

Department of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.

Silvia Garazzino (S)

Infectious Diseases Unit, Department of Pediatrics, Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.

Valentina Daprà (V)

Pediatric Laboratory, Department of Pediatric Sciences and Public Health, University of Turin, 10126 Turin, Italy.

Giulia Pruccoli (G)

Department of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.

Cristina Calvi (C)

Department of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Pediatric Laboratory, Department of Pediatric Sciences and Public Health, University of Turin, 10126 Turin, Italy.

Federica Mignone (F)

Infectious Diseases Unit, Department of Pediatrics, Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.

Carla Alliaudi (C)

Department of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Pediatric Laboratory, Department of Pediatric Sciences and Public Health, University of Turin, 10126 Turin, Italy.

Marco Denina (M)

Department of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.

Carlo Scolfaro (C)

Infectious Diseases Unit, Department of Pediatrics, Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.

Marisa Zoppo (M)

Infectious Diseases Unit, Department of Pediatrics, Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.

Francesco Licciardi (F)

Department of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.

Ugo Ramenghi (U)

Department of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.

Ilaria Galliano (I)

Department of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Pediatric Laboratory, Department of Pediatric Sciences and Public Health, University of Turin, 10126 Turin, Italy.

Massimiliano Bergallo (M)

Department of Pediatric Sciences and Public Health, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Pediatric Laboratory, Department of Pediatric Sciences and Public Health, University of Turin, 10126 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH